Synoptic reporting (SR) increases completeness and improves the understanding of pathology reports for tumours as compared to the more traditional "narrative" style. Furthermore, it is an important step towards higher levels of structured data capture [1] . SR is defined by a set of required data elements (RDE) specific for each tumour type and a characteristic paired format of RDE and response. The College of American Pathologists (CAP) requires accredited pathology laboratories to report many cancer types in a synoptic format and for this purpose publishes a comprehensive set of protocols [2] . More recently, the International Collaboration for Cancer Reporting (ICCR)-sponsored amongst others by the European Society of Pathology-has started to publish synoptic protocols with the aim to "produce internationally standardised and evidencebased datasets for the pathology reporting of cancer" [3] .
One arguably underestimated challenge with regard to widespread implementation of SR is that-with the noteworthy exception of Dutch protocols published by the PALGA foundation [4] -protocols are exclusively available in English. This does not only result in barriers to introduce SR for pathology departments that report in other languages, but also jeopardises one of the main benefits of SR, i.e. uniformity of terminology between institutions, across country and language barriers. The Institute of Pathology at the University of Bern recently launched an initiative for SR of all major cancer types. Given that the Canton of Bern is bilingual (German and French) and that we report in both languages, we sought to define an approach for translating existing protocols to German as well as French, ensuring precision, clarity and consistency between protocols. Because of the currently much more comprehensive set of protocols, we opted to use CAP (rather than ICCR) protocols, which are freely available (with certain restrictions regarding integration into pathology information systems).
Importantly, we identified recurrent terms and ensured that these were translated consistently between the different protocols (Table 1) . We sought to adhere as close as possible to the original English terminology, but found literal translation impracticable for some terms. We made a particular effort to ensure patient safety by avoiding terms prone to misinterpretation. For this purpose, for example, we translated "well differentiated" to German "gut differenziert" rather than the widely used alternative "hoch differenziert"-literally translated "highly differentiated". This was done to avoid confusion with "hochgradig" ("high grade"). We also made sure that positive and negative responses would not differ by only a single word, the accidental omission of which would invert the meaning. For instance, we translated "not identified" to German "nicht nachgewiesen" rather than the more customary term "nicht vorhanden" for a negative finding, which would differ from "vorhanden" ("present") only by the negation "nicht". Sample reports for the lung carcinoma protocol to highlight these points are provided as supplementary data.
Based on our experience with 2 years of SR, 20 surgical and biomarker protocols adopted so far, and more than 1000 synoptic reports issued, we conclude that widespread implementation of SR in languages other than English is feasible, but neither a trivial nor an effortless endeavour.
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All five Swiss academic pathology institutes collaborate to date on PathoLink, a common bilingual (German and French) structured reporting system to enhance data interoperability for cancer registration and data exchange in the frame of personalised health. Nicht nachgewiesen rather than "nicht vorhanden" in order not to differ from "vorhanden" only by one word
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